Findings over the last year or so have built the case that microRNAs might contribute to cancer. Three studies now definitively show this to be the case and also suggest that these small RNAs could be used to categorize tumors.
References
He, L. et al. Nature 435, 828–833 (2005).
O'Donnell K.A. et al. Nature 435, 839–843 (2005).
Lu, J. et al. Nature 435, 834–838 (2005).
Bartel, D.P. Cell 116, 281–297 (2004).
He, L. et al. Nat. Rev. Genet. 5, 522–531 (2004).
Ambros, V. Nature 431, 350–355 (2004).
Lee, R.C. et al. Cell 75, 843–854 (1993).
Reinhart, B.J. et al. Nature 403, 901–906 (2000).
Berezikov, E. et al. Cell 120, 21–24 (2005).
Lewis, B.P. et al. Cell 120, 15–20 (2005).
Krek, A. et al. Nat. Genet. 37, 495–500 (2005).
Calin, G.A. et al. Proc. Natl. Acad. Sci. USA 99, 15524–15529 (2002).
Michael, M.Z. et al. Mol. Cancer Res. 1, 882–891 (2003).
Johnson, S.M. et al. Cell 120, 635–647 (2005).
Dimova, D.K. et al. Oncogene 24, 2810–2826 (2005).
Meltzer, P.S. Nature 435, 745–746 (2005).
Weinberg, R.A. Cell 85, 457–459 (1996).
Weinholds, E. et al. Science published online 26 May 2005 (10.1126/science.1114519).
Iwai, N. et al. Biochem. Biophys. Res. Commun. 331, 1439–1444 (2005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Caldas, C., Brenton, J. Sizing up miRNAs as cancer genes. Nat Med 11, 712–714 (2005). https://doi.org/10.1038/nm0705-712
Issue Date:
DOI: https://doi.org/10.1038/nm0705-712
- Springer Nature America, Inc.
This article is cited by
-
Identification of Dysregulated microRNAs in Glioma Using RNA-sequencing
Current Medical Science (2021)
-
Interactome of miRNAs and transcriptome of human umbilical cord endothelial cells exposed to short-term simulated microgravity
npj Microgravity (2020)
-
Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer
International Journal of Clinical Oncology (2020)
-
MicroRNA-29a inhibits glioblastoma stem cells and tumor growth by regulating the PDGF pathway
Journal of Neuro-Oncology (2019)
-
MiR-629 promotes human pancreatic cancer progression by targeting FOXO3
Cell Death & Disease (2017)